Moderna Covid-19 vaccine authorised in Switzerland for children aged 6 to 11 years
13 May 2022 – Swissmedic has authorised an extension of the indication of the Spikevax® Covid-19 vaccine from Moderna to children aged 6 to 11 years. Children aged 6 years and over, as opposed to adults and adolescents aged 12 years and above, will receive two half doses (50 micrograms), administered at an interval of four weeks. The main study in children aged 6 to 11 years found that the immune response triggered by the vaccine against the SARS-CoV-2 virus is comparable with that in young adults.
For more information, see here.